← Open Payments lookup

AMBER STUTZMAN: Open Payments

NPI 1811566169 · ALBION, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$228 in 13 payments from 9 companies in 2025. Trend: 2023 $190 · 2024 $95 · 2025 $228

Food & beverage: $228
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.3$55
Supernus Pharmaceuticals, Inc.3$51
Corcept Therapeutics1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Neurocrine BioSciences, Inc.1$21
Axsome Therapeutics, Inc.1$20
ABBVIE INC.1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14
Corium, LLC1$10

Products named: Qelbree, Korlym, CAPLYTA, INGREZZA, Auvelity, VRAYLAR, TRINTELLIX, Azstarys.

Industry payments across IN — which companies pay providers there.